nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—Polydipsia—Varenicline—nicotine dependence	0.0189	0.0376	CcSEcCtD
Valproic Acid—Abnormal behaviour—Varenicline—nicotine dependence	0.0158	0.0313	CcSEcCtD
Valproic Acid—OGDH—cardiovascular system—nicotine dependence	0.0149	0.0918	CbGeAlD
Valproic Acid—HDAC9—cardiovascular system—nicotine dependence	0.0131	0.081	CbGeAlD
Valproic Acid—Pancreatitis acute—Varenicline—nicotine dependence	0.0127	0.0253	CcSEcCtD
Valproic Acid—ACADSB—cardiovascular system—nicotine dependence	0.0118	0.073	CbGeAlD
Valproic Acid—Hostility—Varenicline—nicotine dependence	0.0106	0.0211	CcSEcCtD
Valproic Acid—Sleep disturbance—Varenicline—nicotine dependence	0.0105	0.0208	CcSEcCtD
Valproic Acid—Osteoporosis—Varenicline—nicotine dependence	0.0105	0.0208	CcSEcCtD
Valproic Acid—HDAC9—midbrain—nicotine dependence	0.0103	0.0632	CbGeAlD
Valproic Acid—ACADSB—midbrain—nicotine dependence	0.00925	0.057	CbGeAlD
Valproic Acid—CYP2C18—Xenobiotics—CYP2A7—nicotine dependence	0.00906	0.0271	CbGpPWpGaD
Valproic Acid—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00891	0.0267	CbGpPWpGaD
Valproic Acid—Cyst—Varenicline—nicotine dependence	0.00879	0.0174	CcSEcCtD
Valproic Acid—Menstrual disorder—Varenicline—nicotine dependence	0.00862	0.0171	CcSEcCtD
Valproic Acid—Haematemesis—Varenicline—nicotine dependence	0.00845	0.0168	CcSEcCtD
Valproic Acid—Nystagmus—Varenicline—nicotine dependence	0.00822	0.0163	CcSEcCtD
Valproic Acid—ALDH5A1—midbrain—nicotine dependence	0.00814	0.0502	CbGeAlD
Valproic Acid—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0078	0.0155	CcSEcCtD
Valproic Acid—Fungal infection—Varenicline—nicotine dependence	0.00761	0.0151	CcSEcCtD
Valproic Acid—OGDH—brain—nicotine dependence	0.00732	0.0451	CbGeAlD
Valproic Acid—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00719	0.0215	CbGpPWpGaD
Valproic Acid—Endocrine disorder—Varenicline—nicotine dependence	0.00709	0.0141	CcSEcCtD
Valproic Acid—ABAT—midbrain—nicotine dependence	0.00697	0.0429	CbGeAlD
Valproic Acid—Disturbance in attention—Varenicline—nicotine dependence	0.00678	0.0135	CcSEcCtD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00675	0.0202	CbGpPWpGaD
Valproic Acid—HDAC2—cardiovascular system—nicotine dependence	0.00672	0.0414	CbGeAlD
Valproic Acid—Aggression—Varenicline—nicotine dependence	0.00668	0.0133	CcSEcCtD
Valproic Acid—Accidental injury—Varenicline—nicotine dependence	0.00664	0.0132	CcSEcCtD
Valproic Acid—Viral infection—Varenicline—nicotine dependence	0.0065	0.0129	CcSEcCtD
Valproic Acid—HDAC9—brain—nicotine dependence	0.00645	0.0397	CbGeAlD
Valproic Acid—Thinking abnormal—Varenicline—nicotine dependence	0.00642	0.0127	CcSEcCtD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0064	0.0192	CbGpPWpGaD
Valproic Acid—Dysarthria—Varenicline—nicotine dependence	0.00621	0.0123	CcSEcCtD
Valproic Acid—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00608	0.0182	CbGpPWpGaD
Valproic Acid—Coordination abnormal—Varenicline—nicotine dependence	0.00598	0.0119	CcSEcCtD
Valproic Acid—SLC16A1—cardiovascular system—nicotine dependence	0.00597	0.0368	CbGeAlD
Valproic Acid—ACADSB—brain—nicotine dependence	0.00581	0.0358	CbGeAlD
Valproic Acid—Abnormal dreams—Varenicline—nicotine dependence	0.0058	0.0115	CcSEcCtD
Valproic Acid—Eructation—Varenicline—nicotine dependence	0.00577	0.0115	CcSEcCtD
Valproic Acid—Influenza like illness—Varenicline—nicotine dependence	0.0057	0.0113	CcSEcCtD
Valproic Acid—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00561	0.0168	CbGpPWpGaD
Valproic Acid—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00552	0.0165	CbGpPWpGaD
Valproic Acid—Photophobia—Varenicline—nicotine dependence	0.00551	0.011	CcSEcCtD
Valproic Acid—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00543	0.0163	CbGpPWpGaD
Valproic Acid—Dry eye—Varenicline—nicotine dependence	0.00543	0.0108	CcSEcCtD
Valproic Acid—Urine output increased—Varenicline—nicotine dependence	0.00531	0.0105	CcSEcCtD
Valproic Acid—Mouth ulceration—Varenicline—nicotine dependence	0.00531	0.0105	CcSEcCtD
Valproic Acid—HDAC2—midbrain—nicotine dependence	0.00525	0.0323	CbGeAlD
Valproic Acid—ALDH5A1—Neuronal System—CHRNB3—nicotine dependence	0.00518	0.0155	CbGpPWpGaD
Valproic Acid—Hypertonia—Varenicline—nicotine dependence	0.00515	0.0102	CcSEcCtD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00512	0.0153	CbGpPWpGaD
Valproic Acid—ALDH5A1—brain—nicotine dependence	0.00512	0.0315	CbGeAlD
Valproic Acid—Mental disability—Varenicline—nicotine dependence	0.0051	0.0101	CcSEcCtD
Valproic Acid—Euphoric mood—Varenicline—nicotine dependence	0.00505	0.01	CcSEcCtD
Valproic Acid—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00495	0.0148	CbGpPWpGaD
Valproic Acid—UGT1A10—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00494	0.0148	CbGpPWpGaD
Valproic Acid—Sleep disorder—Varenicline—nicotine dependence	0.00493	0.00978	CcSEcCtD
Valproic Acid—ALDH5A1—Neuronal System—CHRNA6—nicotine dependence	0.00491	0.0147	CbGpPWpGaD
Valproic Acid—Polyuria—Varenicline—nicotine dependence	0.00486	0.00964	CcSEcCtD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00485	0.0145	CbGpPWpGaD
Valproic Acid—Deafness—Varenicline—nicotine dependence	0.00477	0.00947	CcSEcCtD
Valproic Acid—Eye pain—Varenicline—nicotine dependence	0.00472	0.00938	CcSEcCtD
Valproic Acid—SLC16A1—midbrain—nicotine dependence	0.00466	0.0287	CbGeAlD
Valproic Acid—Injury—Varenicline—nicotine dependence	0.00464	0.00921	CcSEcCtD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00463	0.0139	CbGpPWpGaD
Valproic Acid—UGT1A10—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00459	0.0137	CbGpPWpGaD
Valproic Acid—Amnesia—Varenicline—nicotine dependence	0.00454	0.00901	CcSEcCtD
Valproic Acid—Increased appetite—Varenicline—nicotine dependence	0.00454	0.00901	CcSEcCtD
Valproic Acid—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00445	0.0133	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00444	0.0133	CbGpPWpGaD
Valproic Acid—ABAT—brain—nicotine dependence	0.00438	0.027	CbGeAlD
Valproic Acid—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00435	0.013	CbGpPWpGaD
Valproic Acid—Lethargy—Varenicline—nicotine dependence	0.00435	0.00864	CcSEcCtD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00435	0.013	CbGpPWpGaD
Valproic Acid—Osteoarthritis—Varenicline—nicotine dependence	0.00426	0.00847	CcSEcCtD
Valproic Acid—Affect lability—Varenicline—nicotine dependence	0.0042	0.00833	CcSEcCtD
Valproic Acid—Psychotic disorder—Varenicline—nicotine dependence	0.00416	0.00827	CcSEcCtD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00413	0.0124	CbGpPWpGaD
Valproic Acid—Mood swings—Varenicline—nicotine dependence	0.00404	0.00802	CcSEcCtD
Valproic Acid—HDAC2—p75 NTR receptor-mediated signalling—FGD1—nicotine dependence	0.004	0.012	CbGpPWpGaD
Valproic Acid—UGT1A8—Biological oxidations—CYP2A7—nicotine dependence	0.00396	0.0118	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—CHRNB3—nicotine dependence	0.00392	0.0117	CbGpPWpGaD
Valproic Acid—Dry skin—Varenicline—nicotine dependence	0.00391	0.00776	CcSEcCtD
Valproic Acid—Abdominal pain upper—Varenicline—nicotine dependence	0.00389	0.00773	CcSEcCtD
Valproic Acid—Breast disorder—Varenicline—nicotine dependence	0.00385	0.00765	CcSEcCtD
Valproic Acid—SLC22A7—brain—nicotine dependence	0.00383	0.0236	CbGeAlD
Valproic Acid—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00377	0.0113	CbGpPWpGaD
Valproic Acid—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00376	0.0113	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—CHRNA6—nicotine dependence	0.00372	0.0111	CbGpPWpGaD
Valproic Acid—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00371	0.0111	CbGpPWpGaD
Valproic Acid—SLC22A6—brain—nicotine dependence	0.0037	0.0228	CbGeAlD
Valproic Acid—Dysphagia—Varenicline—nicotine dependence	0.00369	0.00732	CcSEcCtD
Valproic Acid—ALDH5A1—Neuronal System—GABRA4—nicotine dependence	0.00355	0.0106	CbGpPWpGaD
Valproic Acid—Bronchitis—Varenicline—nicotine dependence	0.00354	0.00704	CcSEcCtD
Valproic Acid—Abdominal discomfort—Varenicline—nicotine dependence	0.00353	0.00702	CcSEcCtD
Valproic Acid—ABAT—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00351	0.0105	CbGpPWpGaD
Valproic Acid—UGT2B15—Biological oxidations—CYP2A7—nicotine dependence	0.00346	0.0104	CbGpPWpGaD
Valproic Acid—Pollakiuria—Varenicline—nicotine dependence	0.0034	0.00676	CcSEcCtD
Valproic Acid—ALDH5A1—Neuronal System—CHRNB4—nicotine dependence	0.0034	0.0102	CbGpPWpGaD
Valproic Acid—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00337	0.0101	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00336	0.0101	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00336	0.0101	CbGpPWpGaD
Valproic Acid—Photosensitivity reaction—Varenicline—nicotine dependence	0.00336	0.00668	CcSEcCtD
Valproic Acid—Weight increased—Varenicline—nicotine dependence	0.00335	0.00666	CcSEcCtD
Valproic Acid—HDAC2—brain—nicotine dependence	0.0033	0.0203	CbGeAlD
Valproic Acid—Depression—Varenicline—nicotine dependence	0.00328	0.00651	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00326	0.00647	CcSEcCtD
Valproic Acid—Stomatitis—Varenicline—nicotine dependence	0.0032	0.00636	CcSEcCtD
Valproic Acid—Conjunctivitis—Varenicline—nicotine dependence	0.00319	0.00634	CcSEcCtD
Valproic Acid—ALDH5A1—Neuronal System—CHRNA5—nicotine dependence	0.00316	0.00946	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00313	0.00936	CbGpPWpGaD
Valproic Acid—Hepatobiliary disease—Varenicline—nicotine dependence	0.00311	0.00617	CcSEcCtD
Valproic Acid—Epistaxis—Varenicline—nicotine dependence	0.0031	0.00615	CcSEcCtD
Valproic Acid—Sinusitis—Varenicline—nicotine dependence	0.00308	0.00612	CcSEcCtD
Valproic Acid—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00307	0.00919	CbGpPWpGaD
Valproic Acid—UGT1A6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00306	0.00917	CbGpPWpGaD
Valproic Acid—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00305	0.00913	CbGpPWpGaD
Valproic Acid—Bradycardia—Varenicline—nicotine dependence	0.003	0.00596	CcSEcCtD
Valproic Acid—CYP2B6—cardiovascular system—nicotine dependence	0.00296	0.0182	CbGeAlD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00296	0.00886	CbGpPWpGaD
Valproic Acid—Hallucination—Varenicline—nicotine dependence	0.00293	0.00583	CcSEcCtD
Valproic Acid—Hypoaesthesia—Varenicline—nicotine dependence	0.00293	0.00583	CcSEcCtD
Valproic Acid—CYP2C9—cardiovascular system—nicotine dependence	0.00293	0.0181	CbGeAlD
Valproic Acid—SLC16A1—brain—nicotine dependence	0.00293	0.018	CbGeAlD
Valproic Acid—Urinary tract disorder—Varenicline—nicotine dependence	0.00291	0.00578	CcSEcCtD
Valproic Acid—Oedema peripheral—Varenicline—nicotine dependence	0.00291	0.00577	CcSEcCtD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0029	0.00868	CbGpPWpGaD
Valproic Acid—Connective tissue disorder—Varenicline—nicotine dependence	0.0029	0.00576	CcSEcCtD
Valproic Acid—Urethral disorder—Varenicline—nicotine dependence	0.00289	0.00574	CcSEcCtD
Valproic Acid—UGT1A6—Biological oxidations—CYP2A7—nicotine dependence	0.00289	0.00864	CbGpPWpGaD
Valproic Acid—CYP2A6—brain—nicotine dependence	0.00289	0.0178	CbGeAlD
Valproic Acid—UGT1A6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00285	0.00853	CbGpPWpGaD
Valproic Acid—Visual impairment—Varenicline—nicotine dependence	0.00284	0.00564	CcSEcCtD
Valproic Acid—Erythema multiforme—Varenicline—nicotine dependence	0.00279	0.00554	CcSEcCtD
Valproic Acid—Eye disorder—Varenicline—nicotine dependence	0.00276	0.00547	CcSEcCtD
Valproic Acid—Tinnitus—Varenicline—nicotine dependence	0.00275	0.00546	CcSEcCtD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00269	0.00805	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—GABRA4—nicotine dependence	0.00269	0.00805	CbGpPWpGaD
Valproic Acid—PTGS1—cardiovascular system—nicotine dependence	0.00268	0.0165	CbGeAlD
Valproic Acid—Angiopathy—Varenicline—nicotine dependence	0.00268	0.00531	CcSEcCtD
Valproic Acid—SLC22A5—midbrain—nicotine dependence	0.00266	0.0164	CbGeAlD
Valproic Acid—Immune system disorder—Varenicline—nicotine dependence	0.00266	0.00529	CcSEcCtD
Valproic Acid—Mediastinal disorder—Varenicline—nicotine dependence	0.00266	0.00528	CcSEcCtD
Valproic Acid—Chills—Varenicline—nicotine dependence	0.00265	0.00526	CcSEcCtD
Valproic Acid—Arrhythmia—Varenicline—nicotine dependence	0.00264	0.00523	CcSEcCtD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00263	0.00788	CbGpPWpGaD
Valproic Acid—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00262	0.00785	CbGpPWpGaD
Valproic Acid—Mental disorder—Varenicline—nicotine dependence	0.00258	0.00513	CcSEcCtD
Valproic Acid—ABAT—Neuronal System—CHRNB4—nicotine dependence	0.00258	0.00771	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—CHRNA3—nicotine dependence	0.00258	0.00771	CbGpPWpGaD
Valproic Acid—Malnutrition—Varenicline—nicotine dependence	0.00257	0.0051	CcSEcCtD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00255	0.00763	CbGpPWpGaD
Valproic Acid—Flatulence—Varenicline—nicotine dependence	0.00253	0.00502	CcSEcCtD
Valproic Acid—Dysgeusia—Varenicline—nicotine dependence	0.00251	0.00499	CcSEcCtD
Valproic Acid—Back pain—Varenicline—nicotine dependence	0.00248	0.00493	CcSEcCtD
Valproic Acid—Muscle spasms—Varenicline—nicotine dependence	0.00247	0.0049	CcSEcCtD
Valproic Acid—Vision blurred—Varenicline—nicotine dependence	0.00242	0.00481	CcSEcCtD
Valproic Acid—Tremor—Varenicline—nicotine dependence	0.00241	0.00478	CcSEcCtD
Valproic Acid—ABAT—Neuronal System—CHRNA5—nicotine dependence	0.0024	0.00717	CbGpPWpGaD
Valproic Acid—Ill-defined disorder—Varenicline—nicotine dependence	0.00238	0.00473	CcSEcCtD
Valproic Acid—Anaemia—Varenicline—nicotine dependence	0.00237	0.00471	CcSEcCtD
Valproic Acid—UGT1A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00237	0.00708	CbGpPWpGaD
Valproic Acid—Agitation—Varenicline—nicotine dependence	0.00236	0.00469	CcSEcCtD
Valproic Acid—Angioedema—Varenicline—nicotine dependence	0.00235	0.00466	CcSEcCtD
Valproic Acid—Malaise—Varenicline—nicotine dependence	0.00232	0.0046	CcSEcCtD
Valproic Acid—Vertigo—Varenicline—nicotine dependence	0.00231	0.00458	CcSEcCtD
Valproic Acid—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00229	0.00686	CbGpPWpGaD
Valproic Acid—Palpitations—Varenicline—nicotine dependence	0.00227	0.00451	CcSEcCtD
Valproic Acid—ALDH5A1—Neuronal System—CHRNB2—nicotine dependence	0.00227	0.00679	CbGpPWpGaD
Valproic Acid—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00226	0.00677	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00224	0.00672	CbGpPWpGaD
Valproic Acid—Cough—Varenicline—nicotine dependence	0.00224	0.00445	CcSEcCtD
Valproic Acid—UGT1A4—Biological oxidations—CYP2A7—nicotine dependence	0.00223	0.00667	CbGpPWpGaD
Valproic Acid—Hypertension—Varenicline—nicotine dependence	0.00222	0.0044	CcSEcCtD
Valproic Acid—SLC22A8—brain—nicotine dependence	0.00222	0.0136	CbGeAlD
Valproic Acid—UGT1A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0022	0.00658	CbGpPWpGaD
Valproic Acid—Chest pain—Varenicline—nicotine dependence	0.00219	0.00434	CcSEcCtD
Valproic Acid—Arthralgia—Varenicline—nicotine dependence	0.00219	0.00434	CcSEcCtD
Valproic Acid—Myalgia—Varenicline—nicotine dependence	0.00219	0.00434	CcSEcCtD
Valproic Acid—Anxiety—Varenicline—nicotine dependence	0.00218	0.00433	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00217	0.00431	CcSEcCtD
Valproic Acid—Discomfort—Varenicline—nicotine dependence	0.00216	0.00429	CcSEcCtD
Valproic Acid—Dry mouth—Varenicline—nicotine dependence	0.00214	0.00425	CcSEcCtD
Valproic Acid—Oedema—Varenicline—nicotine dependence	0.0021	0.00416	CcSEcCtD
Valproic Acid—Infection—Varenicline—nicotine dependence	0.00208	0.00413	CcSEcCtD
Valproic Acid—ALDH5A1—Neuronal System—CHRNA4—nicotine dependence	0.00206	0.00617	CbGpPWpGaD
Valproic Acid—Nervous system disorder—Varenicline—nicotine dependence	0.00206	0.00408	CcSEcCtD
Valproic Acid—Thrombocytopenia—Varenicline—nicotine dependence	0.00205	0.00407	CcSEcCtD
Valproic Acid—Tachycardia—Varenicline—nicotine dependence	0.00205	0.00406	CcSEcCtD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00204	0.0061	CbGpPWpGaD
Valproic Acid—Skin disorder—Varenicline—nicotine dependence	0.00204	0.00404	CcSEcCtD
Valproic Acid—Hyperhidrosis—Varenicline—nicotine dependence	0.00203	0.00402	CcSEcCtD
Valproic Acid—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00202	0.00606	CbGpPWpGaD
Valproic Acid—Anorexia—Varenicline—nicotine dependence	0.002	0.00397	CcSEcCtD
Valproic Acid—UGT1A3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00197	0.00589	CbGpPWpGaD
Valproic Acid—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00197	0.00588	CbGpPWpGaD
Valproic Acid—Hypotension—Varenicline—nicotine dependence	0.00196	0.00389	CcSEcCtD
Valproic Acid—ABAT—Neuronal System—CHRNA3—nicotine dependence	0.00195	0.00585	CbGpPWpGaD
Valproic Acid—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00191	0.00379	CcSEcCtD
Valproic Acid—Insomnia—Varenicline—nicotine dependence	0.0019	0.00376	CcSEcCtD
Valproic Acid—Dyspnoea—Varenicline—nicotine dependence	0.00187	0.00371	CcSEcCtD
Valproic Acid—Somnolence—Varenicline—nicotine dependence	0.00186	0.0037	CcSEcCtD
Valproic Acid—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00186	0.00556	CbGpPWpGaD
Valproic Acid—UGT1A3—Biological oxidations—CYP2A7—nicotine dependence	0.00185	0.00555	CbGpPWpGaD
Valproic Acid—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00185	0.00554	CbGpPWpGaD
Valproic Acid—Dyspepsia—Varenicline—nicotine dependence	0.00184	0.00366	CcSEcCtD
Valproic Acid—UGT1A3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00183	0.00547	CbGpPWpGaD
Valproic Acid—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00183	0.00546	CbGpPWpGaD
Valproic Acid—Decreased appetite—Varenicline—nicotine dependence	0.00182	0.00362	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00181	0.00359	CcSEcCtD
Valproic Acid—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00181	0.00541	CbGpPWpGaD
Valproic Acid—Fatigue—Varenicline—nicotine dependence	0.00181	0.00359	CcSEcCtD
Valproic Acid—Pain—Varenicline—nicotine dependence	0.00179	0.00356	CcSEcCtD
Valproic Acid—Constipation—Varenicline—nicotine dependence	0.00179	0.00356	CcSEcCtD
Valproic Acid—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00178	0.00534	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Varenicline—nicotine dependence	0.00173	0.00343	CcSEcCtD
Valproic Acid—ABAT—Neuronal System—CHRNB2—nicotine dependence	0.00172	0.00515	CbGpPWpGaD
Valproic Acid—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00172	0.00514	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Varenicline—nicotine dependence	0.00171	0.0034	CcSEcCtD
Valproic Acid—SLC22A5—brain—nicotine dependence	0.00167	0.0103	CbGeAlD
Valproic Acid—UGT2B7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00167	0.005	CbGpPWpGaD
Valproic Acid—Urticaria—Varenicline—nicotine dependence	0.00166	0.00331	CcSEcCtD
Valproic Acid—Body temperature increased—Varenicline—nicotine dependence	0.00166	0.00329	CcSEcCtD
Valproic Acid—Abdominal pain—Varenicline—nicotine dependence	0.00166	0.00329	CcSEcCtD
Valproic Acid—CYP2C8—brain—nicotine dependence	0.00162	0.00998	CbGeAlD
Valproic Acid—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.00162	0.00485	CbGpPWpGaD
Valproic Acid—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0016	0.00478	CbGpPWpGaD
Valproic Acid—UGT2B7—Biological oxidations—CYP2A7—nicotine dependence	0.00158	0.00472	CbGpPWpGaD
Valproic Acid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00157	0.00469	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—CHRNA4—nicotine dependence	0.00156	0.00467	CbGpPWpGaD
Valproic Acid—UGT2B7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00155	0.00465	CbGpPWpGaD
Valproic Acid—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00155	0.00463	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Varenicline—nicotine dependence	0.00154	0.00307	CcSEcCtD
Valproic Acid—Asthenia—Varenicline—nicotine dependence	0.0015	0.00299	CcSEcCtD
Valproic Acid—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0015	0.00449	CbGpPWpGaD
Valproic Acid—Pruritus—Varenicline—nicotine dependence	0.00148	0.00294	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—FGD1—nicotine dependence	0.00147	0.00441	CbGpPWpGaD
Valproic Acid—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00147	0.00439	CbGpPWpGaD
Valproic Acid—CYP2B6—brain—nicotine dependence	0.00145	0.00896	CbGeAlD
Valproic Acid—Diarrhoea—Varenicline—nicotine dependence	0.00143	0.00285	CcSEcCtD
Valproic Acid—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0014	0.00418	CbGpPWpGaD
Valproic Acid—Dizziness—Varenicline—nicotine dependence	0.00139	0.00275	CcSEcCtD
Valproic Acid—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00138	0.00413	CbGpPWpGaD
Valproic Acid—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00136	0.00407	CbGpPWpGaD
Valproic Acid—Vomiting—Varenicline—nicotine dependence	0.00133	0.00265	CcSEcCtD
Valproic Acid—Rash—Varenicline—nicotine dependence	0.00132	0.00262	CcSEcCtD
Valproic Acid—Dermatitis—Varenicline—nicotine dependence	0.00132	0.00262	CcSEcCtD
Valproic Acid—PTGS1—brain—nicotine dependence	0.00131	0.0081	CbGeAlD
Valproic Acid—Headache—Varenicline—nicotine dependence	0.00131	0.00261	CcSEcCtD
Valproic Acid—ACADSB—Metabolism—CYP2A7—nicotine dependence	0.00129	0.00386	CbGpPWpGaD
Valproic Acid—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.00128	0.00383	CbGpPWpGaD
Valproic Acid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00127	0.00381	CbGpPWpGaD
Valproic Acid—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00127	0.0038	CbGpPWpGaD
Valproic Acid—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00126	0.00378	CbGpPWpGaD
Valproic Acid—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00126	0.00376	CbGpPWpGaD
Valproic Acid—Nausea—Varenicline—nicotine dependence	0.00124	0.00247	CcSEcCtD
Valproic Acid—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00113	0.00339	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—CYP2A7—nicotine dependence	0.0011	0.00328	CbGpPWpGaD
Valproic Acid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00109	0.00326	CbGpPWpGaD
Valproic Acid—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00107	0.00322	CbGpPWpGaD
Valproic Acid—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00104	0.00312	CbGpPWpGaD
Valproic Acid—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00103	0.00309	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00103	0.00307	CbGpPWpGaD
Valproic Acid—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.000987	0.00295	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TAS2R16—nicotine dependence	0.00093	0.00278	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—AKR1B10—nicotine dependence	0.000921	0.00276	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000883	0.00264	CbGpPWpGaD
Valproic Acid—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000845	0.00253	CbGpPWpGaD
Valproic Acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00084	0.00252	CbGpPWpGaD
Valproic Acid—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000829	0.00248	CbGpPWpGaD
Valproic Acid—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000826	0.00247	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000796	0.00238	CbGpPWpGaD
Valproic Acid—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000786	0.00235	CbGpPWpGaD
Valproic Acid—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000779	0.00233	CbGpPWpGaD
Valproic Acid—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000768	0.0023	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—DRD2—nicotine dependence	0.000759	0.00227	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FGD1—nicotine dependence	0.00073	0.00218	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000726	0.00217	CbGpPWpGaD
Valproic Acid—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000715	0.00214	CbGpPWpGaD
Valproic Acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000681	0.00204	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CYP2A7—nicotine dependence	0.000677	0.00203	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000674	0.00202	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000671	0.00201	CbGpPWpGaD
Valproic Acid—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000665	0.00199	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKR1B10—nicotine dependence	0.000645	0.00193	CbGpPWpGaD
Valproic Acid—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000639	0.00191	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000624	0.00187	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—CCAR1—nicotine dependence	0.00062	0.00186	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000602	0.0018	CbGpPWpGaD
Valproic Acid—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000594	0.00178	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CYP2A7—nicotine dependence	0.000592	0.00177	CbGpPWpGaD
Valproic Acid—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000582	0.00174	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000564	0.00169	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000549	0.00164	CbGpPWpGaD
Valproic Acid—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000541	0.00162	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000498	0.00149	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CYP2A7—nicotine dependence	0.000494	0.00148	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000471	0.00141	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000469	0.0014	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000463	0.00138	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—WASF2—nicotine dependence	0.000454	0.00136	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—WASF1—nicotine dependence	0.000436	0.0013	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TAS2R16—nicotine dependence	0.000403	0.00121	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKR1B10—nicotine dependence	0.000399	0.0012	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—OPRM1—nicotine dependence	0.000392	0.00117	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000384	0.00115	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CYP2A7—nicotine dependence	0.000381	0.00114	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000362	0.00108	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000357	0.00107	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CYP2A7—nicotine dependence	0.00034	0.00102	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CYP2A7—nicotine dependence	0.000317	0.000949	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FGD1—nicotine dependence	0.000316	0.000947	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—DRD2—nicotine dependence	0.000283	0.000849	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKR1B10—nicotine dependence	0.00028	0.000837	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.000277	0.000829	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP2A7—nicotine dependence	0.00027	0.000807	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.000219	0.000656	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—WASF2—nicotine dependence	0.000197	0.00059	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—WASF1—nicotine dependence	0.000189	0.000565	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000179	0.000534	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—OPRM1—nicotine dependence	0.00017	0.000509	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000169	0.000505	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000136	0.000408	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000133	0.000399	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—DRD2—nicotine dependence	0.000123	0.000368	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000115	0.000345	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000103	0.000308	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP2A7—nicotine dependence	9.39e-05	0.000281	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP2A7—nicotine dependence	8.02e-05	0.00024	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP2A7—nicotine dependence	6.19e-05	0.000185	CbGpPWpGaD
